Home › Myriad Genetics Upgraded by Credit Suisse to "Neutral"
 

Keywords :   


Myriad Genetics Upgraded by Credit Suisse to "Neutral"

2014-02-09 03:19:34| Biotech - Topix.net

The firm currently has a $29.00 target price on the stock. Credit Suisse's price objective indicates a potential downside of 10.02% from the stock's previous close.

Tags: credit suisse neutral genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.11
28.11MF MFsoftbord twintown
28.11T800
28.11162
28.112 117
28.112CD+DVD
28.114
28.11Nike Iowa 90s
More »